We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.25%
AUM
$479M
AUM Growth
-$10.6M
Cap. Flow
-$2.55M
Cap. Flow %
-0.53%
Top 10 Hldgs %
33.46%
Holding
195
New
7
Increased
52
Reduced
73
Closed
5

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.67M
2
AAPL icon
Apple
AAPL
+$2.81M
3
MSFT icon
Microsoft
MSFT
+$1.57M
4
PCAR icon
PACCAR
PCAR
+$843K
5
WAT icon
Waters Corp
WAT
+$774K

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Industrials 16.28%
3 Healthcare 13.72%
4 Consumer Staples 10.28%
5 Energy 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
176
Kinder Morgan
KMI
$69.7B
$219K 0.05%
7,671
AIVL icon
177
WisdomTree US AI Enhanced Value Fund
AIVL
$433M
$216K 0.05%
1,970
ADI icon
178
Analog Devices
ADI
$184B
$210K 0.04%
1,040
UNH icon
179
UnitedHealth
UNH
$367B
$205K 0.04%
+392
New +$200K
WMT icon
180
Walmart Inc
WMT
$892B
$205K 0.04%
2,336
XLE icon
181
State Street Energy Select Sector SPDR ETF
XLE
$38.1B
$201K 0.04%
+4,294
New +$194K
ERIC icon
182
Ericsson
ERIC
$33.3B
$173K 0.04%
22,300
KYN icon
183
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
$131K 0.03%
10,228
+185
+2% +$2.39K
AMP icon
184
Ameriprise Financial
AMP
$49.5B
-400
Closed -$213K
BIIB icon
185
Biogen
BIIB
$30.5B
-1,330
Closed -$203K
SCHO icon
186
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
-8,411
Closed -$202K
V icon
187
Visa
V
$692B
-846
Closed -$267K
VUG icon
188
Vanguard Morningstar Growth ETF
VUG
$229B
-2,982
Closed -$204K

Similar funds

Mengis Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Mengis Capital Management held 195 positions worth $479M, down 2.2% from $490M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Mengis Capital Management's Q1 2025 filing shows 7 new, 52 increased, 73 reduced and 5 closed positions. Its largest new stake was AstraZeneca: 30,355 shares worth $4.46M. The largest sale was Merck, an estimated $3.67M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Mengis Capital Management's largest Q1 2025 buy was AstraZeneca: 30,355 shares worth $4.46M.
  • Mengis Capital Management added most to PepsiCo in Q1 2025, an estimated $765K increase.
  • Mengis Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $3.67M.
  • Mengis Capital Management fully exited Visa in Q1 2025, selling an estimated $267K.
  • Mengis Capital Management's ten largest holdings make up 33% of its $479M portfolio in Q1 2025.
  • Mengis Capital Management opened 7 new positions and closed 5 in Q1 2025.
  • Mengis Capital Management's portfolio value fell 2.2% quarter-over-quarter to $479M.

Based on Mengis Capital Management's 13F filing for Q1 2025, filed 8 May 2025.